1720 logo

Standard Chemical & Pharmaceutical Co., Ltd. Stock Price

TWSE:1720 Community·NT$11.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

1720 Share Price Performance

NT$61.60
3.70 (6.39%)
NT$61.60
3.70 (6.39%)
Price NT$61.60

1720 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with solid track record and pays a dividend.

1 Risk
2 Rewards

Standard Chemical & Pharmaceutical Co., Ltd. Key Details

NT$7.0b

Revenue

NT$4.1b

Cost of Revenue

NT$2.9b

Gross Profit

NT$2.0b

Other Expenses

NT$964.5m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
5.40
41.64%
13.71%
7.6%
View Full Analysis

About 1720

Founded
1967
Employees
n/a
CEO
Tzu-Ting Fan
WebsiteView website
www.standard.com.tw

Standard Chemical & Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese and western medicines, cosmetics, beverages, general instruments, and medical devices. It also provides western pharmaceuticals for cardiovascular, metabolic, genitourinary and sex steroids, respiratory, musculoskeletal, digestive, nervous, and circulatory systems; anti-infectives and topical medications; and cancer and cancer antiemetic. In addition, the company offers health food products. Further, it is involved in the manufacture and sale of active pharmaceutical ingredients, as well as veterinary drugs; and sales of medical devices and infant milk powder. It also exports its products. The company was incorporated in 1967 and is headquartered in Tainan City, Taiwan.

Recent 1720 News & Updates

Recent updates

No updates